Parexel

A truly inspiring week at #CNSSummit2024 🌟📸 Scroll through below to see our team continuing to shine on stage this year, presenting and collaborating with industry leaders! 🎤 Peyton Howell joined a panel of chief executives to discuss lessons learned from the past 15 years of CNS Summit. 🎤 Kushal Gohil presented a session on whether there's a "first mover advantage" in the world of DCT. He later joined a panel of experts on the main stage to discuss the state of the DCT field as a whole. 🎤 In one of her two sessions, Stacy Hurt 🌻 shared her thoughts on using eCOA/ePRO to support all clinical trial constituents to a full room of stakeholders. 🎤 Stephen Pyke presented on #AI implementation and how biopharma is applying it strategically to release value. Our team enjoyed connecting with old friends and forging new relationships this year. We can't wait to continue the conversations and see you again soon! #CNSSummit #CNS #Biopharma #WithHeart

The Parexel team is on-site in Washington, D.C. tomorrow for ACR Convergence 2024! 🎉 This year, we are pleased to have our new Global Section Head of Immunology & Inflammation, Lachy McLean, attending! Lachy brings extensive medical and drug development expertise with experience in rheumatoid arthritis, gout, systemic lupus erythematosus, lupus nephritis, inflammatory bowel disease, psoriasis, osteoarthritis and orphan disease. He now leads a team of physicians, all subject matter experts specializing in understanding the mechanisms underlying disorders in this area. 📍 Meet Lachy and our team of rheumatology experts at booth 3137-G 🤝 To learn about our attendees or schedule a meeting with us in advance, click here: LinkedIn: https://lnkd.in/gzQHyr8Y We look forward to seeing you there! #ACR24 #ACRConvergence #Rheumatology #ClinicalResearch American College of Rheumatology

After nearly 14 years of draft guidance, the #FDA published the final guidance for industry on Pharmacokinetics in Patients with Impaired Renal Function 📝 ❗ In this edition of the New Medicines, Novel Insights newsletter, Parexel regulatory experts Sheryl Perry, Dr Matthias Kruse and Simona Stankeviciute discuss the history and evolution of the FDA's approach in this field and provide five specific areas to consider in the assessment of draft to final guidance. Bring innovative therapies to patients more efficiently and effectively. Read the article below and subscribe to receive the latest #NovelInsights weekly! #Pharmacokinetics #Regulatory #RegulatoryAffairs #WithHeart

We're off and running at #CNSSummit2024! ⭐ This morning, our CEO Peyton Howell joined a panel of chief executives moderated by Craig Lipset to discuss lessons learned from the past 15 years of the CNS Summit and some predictions and aspirations we need to be planning for in the future. Peyton noted that "We have to make clinical trials easier - they're not as adaptive as they should be. I'm hopeful that in the next 15 years we will make adaptive clinical trials the norm." Stacy Hurt 🌻, Parexel's Chief Patient Officer, joined an incredible host lineup to celebrate not only 15 years of this event, but 10 years of personally surviving stage 4 colorectal cancer. 💙 👏 Be sure to catch our presentations this week and stop by booth 404! We look forward to meeting and learning with you all as we navigate the future of the clinical trial industry. #CNSSummit #CNS #LifeSciences #PatientsFirst #WithHeart

In honor of #VeteransDay and #ArmisticeDay, Parexel colleagues joined Veterans Bridge Home (VBH) at Freedom Park in Cary, N.C., to lay flags in recognition of those who served in the US armed forces. At Parexel, we value our veteran colleagues' commitment to serving others, which is a valuable trait that they bring to our patient-focused mission. Since the launch of our "Supporting our Military Community" program in April 2023, we have launched a veteran internship program, hosted opportunities for volunteering in our local community, and expanded support resources for our veteran colleagues and their families. We're proud to support VBH's mission to connect veterans and their families to vital community resources. Read more about their work and our partnership in the Charlotte Business Journal: 👇 https://lnkd.in/gdk6A2fW

At Parexel, we've built a culture that empowers you to thrive personally and professionally: 🏡 Flexibility: Choose the work arrangement that best suits you: in-office, home-based or hybrid. 🩺Comprehensive benefits: Stay healthy with a benefits package that addresses your physical, mental, financial and social health. 🌟 Recognition: Recognize and be recognized for contributions year-round through our "Bravo!" program. Learn more about our work culture and benefits here: https://insde.co/lhaw #ParexelWithHeart #WorkCulture

🔍 What are the visionaries in life sciences predicting for the future of our industry? Find out at this year’s CNS Summit where our CEO Peyton Howell will discuss her top predictions about the future of the industry along with Craig Lipset and leaders from uMotif, Medable, Inc, CenExel and Brooklyn Health. Parexel's Chief Strategy Officer Kushal Gohil will join a panel discussing the value, challenges and next steps for digital tools in #healthtech and shares the current state of decentralized clinical trials and what lies ahead. Our Chief Clinical Data & Digital Officer Stephen Pyke explores the AI implementation journey and how to overcome the practical challenges of delivering AI solutions in a highly-regulated environment, while Chief Patient Officer Stacy Hurt 🌻 will look at taking a people-first approach to collecting clinical trial data with fellow patient advocate Christine Von Raesfeld. 💜 Connect with us at the CNS Summit and be part of the conversation on advancing #clinicalresearch and transforming patient experiences. Check back for more updates on our sessions! #CNSSummit #CNSSummit2024 #CNS #innovation #collaboration #lifesciences

In this Q&A with Xoli Belgrave, featured in our report 'Accelerating the New Frontiers in Neuroscience,' we explore the concept of true diversity in clinical trials. This insightful discussion delves into patient limitations, challenges in diagnosis and participation, and crucial considerations for developers aiming to enhance their trial data through diverse populations. For expert insights on achieving diversity in neuroscience clinical trials, read the full article now: https://lnkd.in/gC3edCnA #Neuroscience #PatientsFirst #PatientDiversity #DEI

Clinical trials fail for various reasons; however, assessing the feasibility of a study’s design before it starts can mitigate or avoid many of the risks unique to neuroscience studies. In this edition of the New Medicines, Novel Insights newsletter, neuroscience and feasibility experts Karen McIntyre MSc Clinical Trials, Jaime-Louise Roberts and Jessica Sheldon, MPH review six critical factors sponsors should be focused on when analyzing study risk. Identifying and quantifying risks precisely creates an impetus for action. Read how high-quality feasibility testing is helping sponsors optimize protocols and plan for success. #NovelInsights #Neuroscience #Feasibility #ClinicalTrials

🌟 Parexel India's 13th Annual Symposium was a huge success! 🌟 Industry leaders recently gathered in Hyderabad to discuss innovative ways to shape the future of clinical research in India. Highlights included: 🔹 51 representatives from 15 sponsor organizations 🔹 Insightful sessions on study launch excellence and EU-CTR 🔹 Expert panels on enhancing patient journeys and regulatory strategies 🔹 Engaging discussions on personalized medicine and site-centricity A big thank you to all participants for making this event special! Together, we're advancing clinical trials and improving patient outcomes in India and beyond. #ParexelIndia #ClinicalTrials #HealthcareInnovation